Assessment of 1 mg Dexamethasone Suppression Test in Patients with Obesity Before Bariatric Surgery

dc.contributor.author	Yavuz, D.G.
dc.contributor.author	Apaydin, T.
dc.contributor.author	Gunhan, H.G.
dc.contributor.author	Uygur, M.M.
dc.date.accessioned	2021-12-21T08:40:40Z
dc.date.available	2021-12-21T08:40:40Z
dc.date.issued	2020
dc.identifier.issn	9608923
dc.identifier.uri	https://doi.org/10.1007/s11695-020-04865-x
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1138
dc.description.abstract	Purpose: This study aims to examine the prevalence of Cushing’s syndrome (CS) in class 3 obese patients before bariatric surgery. Materials and Methods: The data of 1037 class 3 obese patients admitted to the endocrinology outpatient clinic for endocrinol
dc.language.iso	English
dc.publisher	Springer
dc.title	Assessment of 1 mg Dexamethasone Suppression Test in Patients with Obesity Before Bariatric Surgery
dc.type	Article
dc.relation.journal	Obesity Surgery
dc.identifier.issue	12
dc.identifier.startpage	4981
dc.identifier.endpage	4985
dc.identifier.volume	30
dc.identifier.doi	10.1007/s11695-020-04865-x
dc.relation.issue	12
dc.relation.volume	30